These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2792905)

  • 1. Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report.
    Piver MS; Malfetano J; Baker TR; Lele SB; Marchetti DL
    Gynecol Oncol; 1989 Oct; 35(1):69-72. PubMed ID: 2792905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report.
    Piver MS; Malfetano J; Hempling RE; Baker TR; Driscoll DL
    Gynecol Oncol; 1990 Dec; 39(3):249-52. PubMed ID: 2258065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.
    Sutton GP; Stehman FB; Einhorn LH; Roth LM; Blessing JA; Ehrlich CE
    J Clin Oncol; 1989 Feb; 7(2):223-9. PubMed ID: 2915238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
    Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
    Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study.
    Omura G; Blessing JA; Ehrlich CE; Miller A; Yordan E; Creasman WT; Homesley HD
    Cancer; 1986 May; 57(9):1725-30. PubMed ID: 3513943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma arising from a mature cystic teratoma of the ovary: a case report of successful treatment with cisplatin-based chemotherapy.
    Nasu K; Matsui N; Kawano Y; Narahara H; Hayata T; Miyakawa I
    Gynecol Obstet Invest; 1996; 41(2):143-6. PubMed ID: 8838978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma.
    Baker TR; Piver MS; Hempling RE
    Cancer; 1994 Jul; 74(2):656-63. PubMed ID: 8033045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal cisplatin with intravenous cyclophosphamide and doxorubicin for previously untreated stage III and IV ovarian carcinoma.
    Young JA; Garretson F; Westlake DL; Illig WP; Vogl SE
    Cancer Invest; 1989; 7(6):565-70. PubMed ID: 2630007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide.
    Gershenson DM; Copeland LJ; Kavanagh JJ; Stringer CA; Saul PB; Wharton JT
    Obstet Gynecol; 1987 Nov; 70(5):765-9. PubMed ID: 3658288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-based chemotherapy in advanced ovarian cancer: initial experience in an Indian set-up.
    Charak BS; Agarwala S; Gopal R; Advani SH; Nadkarni KS; Pai VR; Saikia TK; Desai PB
    Indian J Cancer; 1989 Jun; 26(2):85-91. PubMed ID: 2592001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.
    Piver MS; Malfetano J; Baker TR; Hempling RE
    Gynecol Oncol; 1992 Sep; 46(3):357-60. PubMed ID: 1526515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
    Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
    Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does negative clinical evaluation of ovarian carcinoma after full course of chemotherapy correlate with second-look laparotomy findings?
    Zorlu CG; Cobanoglu O; Caglar T; Ergun Y; Kuscu E; Alaybeyoglu T
    J Surg Oncol; 1994 Apr; 55(4):255-8. PubMed ID: 8159008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after chemotherapy with cisplatinum, adriamycin and cyclophosphamide for carcinoma of the ovary.
    Davidson NG; Khanna S; Kirwan PH; Naftalin NJ; Roy UK; Chui D; Mitchell S
    Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):206-9. PubMed ID: 2261416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.
    Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y
    Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-diamminedichloroplatinum (II): second line induction chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Barlow JJ; Lele SB; Malfetano JH; McPhee ME
    J Surg Oncol; 1983 Dec; 24(4):329-31. PubMed ID: 6418977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.